Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Century Communities | CCS | Nov 25, 2024 | 94.59 | +6.65 |
Century Therapeutics | IPSC | Nov 25, 2024 | 1.30 | +7.44 |
Cepton | CPTN | Nov 25, 2024 | 3.12 | 0.00 |
Ceragon Networks | CRNT | Nov 25, 2024 | 4.06 | +9.73 |
Cerence | CRNC | Nov 25, 2024 | 7.06 | -1.94 |
CeriBell | CBLL | Nov 25, 2024 | 28.94 | 0.00 |
CERo Therapeutics | CERO | Nov 25, 2024 | 0.17 | -20.45 |
Certara | CERT | Nov 25, 2024 | 11.05 | +6.66 |
Cerus | CERS | Nov 25, 2024 | 1.82 | +1.68 |
CervoMed | CRVO | Nov 25, 2024 | 8.76 | -8.75 |
CEVA | CEVA | Nov 25, 2024 | 30.27 | -0.56 |
CF Acquisition VII A | CFFS | Nov 25, 2024 | 11.20 | +0.72 |
CF Bankshares | CFBK | Nov 25, 2024 | 28.00 | +2.28 |
CF Industries | CF | Nov 25, 2024 | 87.39 | -2.67 |
CFSB Bancorp | CFSB | Nov 25, 2024 | 6.64 | -2.35 |
CG Oncology | CGON | Nov 25, 2024 | 33.95 | +1.43 |
CGI | GIB | Nov 25, 2024 | 112.60 | +0.90 |
Chain Bridge Bancorp | CBNA | Nov 25, 2024 | 24.00 | 0.00 |
Chain Bridge I SPAC A | CBRG | Nov 25, 2024 | 11.49 | 0.00 |
Chain Bridge I Units | CBRGU | Nov 25, 2024 | 11.26 | 0.00 |
Champion Homes | SKY | Nov 25, 2024 | 104.25 | +2.11 |
Champions Oncology | CSBR | Nov 25, 2024 | 4.18 | -8.13 |
ChampionX | CHX | Nov 25, 2024 | 30.92 | -1.02 |
Channel Therapeutics | CHRO | Nov 25, 2024 | 0.60 | -8.64 |
Chanson International | CHSN | Nov 25, 2024 | 7.27 | -3.07 |
ChargePoint | CHPT | Nov 25, 2024 | 1.25 | +8.70 |
Charles & Colvard | CTHR | Nov 25, 2024 | 1.29 | -1.15 |
Charles River Laboratories International | CRL | Nov 25, 2024 | 201.30 | +2.82 |
Charles Schwab | SCHW | Nov 25, 2024 | 81.77 | +0.63 |
Charlton Aria Acquisition Unit | CHARU | Nov 25, 2024 | 9.99 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.